The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
✍ Scribed by L. P. L. GILISSEN; J. BIERAU; L. J. J. DERIJKS; L. P. BOS; P. M. HOOYMANS; A. VAN GENNIP; R. W. STOCKBRÜGGER; L. G. J. B. ENGELS
- Book ID
- 108604238
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 118 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The effect on bladder function of protectomy for colitis or Crohn's disease was studied by means of a questionnaire and by pressure/flow cystometry. Thirty-seven patients who had undergone protectomy for inflammatory bowel disease were compared with 34 control patients who had undergone
## Background: Inflammatory bowel diseases (ibd) such as ulcerative colitis (uc) and crohn's disease (cd) have great impact on patients' health-related quality of life (hrqol). the aim of this study was to develop an integrated medical and psychological/ psychosocial group-based intervention progra